~~<i id='538BA80B9A'><strike id='538BA80B9A'><tt id='538BA80B9A'><pre id='538BA80B9A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

knowledge

author：hotspot 2025-10-04 04:00:36 - browse：47592

LONDON — GSK said Tuesday it would purchase the asthma-focused drug developer Aiolos Bio for $1 billion upfront, the latest in a string of pharma acquisitions that are bolstering hopes for the industry’s year ahead.

The deal includes up to another $400 million in payments if certain milestones are met.

Aiolos was launched just last year, based in both San Francisco and London. The company, which announced a $245 million Series A round in October, has been readying a Phase 2 trial of its candidate AIO-001 in adult asthma.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： J&J to buy cancer drug developer Ambrx Biopharma

entertainment

knowledge

focus

entertainment

focus

entertainment

AdobeResearchersmayhaveanewwaytowatchthebrainpulse,thankstoanultrasoundprobeandatinywindowintheskull

WSS

Addiction doctors spar with methadone clinics over legislation

J&J to buy cancer drug developer Ambrx Biopharma

Prosthetic arm enables patients to feel the objects they grip

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

Federal weight loss drug coverage is 30 years out of date

Biohaven protein

focus

knowledge

entertainment

Heart attack and stroke risk calculators need revising

New weight loss drugs work. But how can they best be used?

In Memoriam: Notable people who died in 2023

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Activists slam private health insurers over coverage restrictions

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

In Memoriam: Notable people who died in 2023

Scientists successfully use ultrasound imaging to map brain activity

ChatGPT in medicine: STAT answers readers' burning questions

Latest bird flu infection made farmworker sicker than earlier cases

knowledge

UCB departs biotech trade group BIO

Prosthetic arm enables patients to feel the objects they grip

Akili, maker of video game for ADHD, to be acquired for 34 million

U.K. sequencing study surfaces new findings about tumor DNA

Feng Zhang, Grail founder join forces on new gene editing startup

Startling documents reveal new facets of Sacklers' opioid empire

focus

entertainment

focus

entertainment